Kim Seung Young, Jung Sung Woo, Choe Jung Wan, Hyun Jong Jin, Jung Young Kul, Koo Ja Seol, Yim Hyung Joon, Lee Sang Woo
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jukgumro, Danwon-gu, Ansan, Gyeonggi-do, 425-707, Korea.
Dig Dis Sci. 2016 Dec;61(12):3560-3564. doi: 10.1007/s10620-016-4325-9. Epub 2016 Sep 30.
Abdominal pain is a common complaint following endoscopic resection (ER).
To investigate the predictive factors for abdominal pain after ER.
Patients who were scheduled to undergo endoscopic mucosal resection or endoscopic submucosal dissection for the treatment of gastric adenoma or cancer were prospectively enrolled. Pain scores were checked every 6 h after ER and whenever patients complained of pain by using a 0-10 pain scale. If the pain score exceeded 5, 25 mg of intravenous (IV) pethidine was administered.
Among 156 patients who underwent ER, 66 (42.3 %) received IV pethidine due to moderate/severe abdominal pain. Both the number of patients complaining of abdominal pain and the pain scores decreased with time following the procedure, with only a few patients complaining of mild abdominal pain 2 days after ER. Multivariate analysis showed that female sex [odds ratio (OR) 2.88; confidence interval (CI) 1.31-6.33], tumor location in the lower third of the stomach (OR 5.46; CI 2.31-12.92), and procedures time more than 60 min (OR 2.96; CI 1.26-6.98) were significant predictive factors for developing pain after ER.
Female sex, tumor location in the lower third of the stomach, and longer procedure time were significantly associated with pain after ER. Close monitoring and active management of pain is recommended for patients who have these risk factors. With these efforts, the majority of patients could experience pain relief within 2 days after the procedure.
腹痛是内镜切除术后常见的主诉。
探讨内镜切除术后腹痛的预测因素。
前瞻性纳入计划接受内镜黏膜切除术或内镜黏膜下剥离术治疗胃腺瘤或癌症的患者。内镜切除术后每6小时检查疼痛评分,患者每次主诉疼痛时使用0-10疼痛量表进行评估。若疼痛评分超过5分,则静脉注射25mg哌替啶。
156例行内镜切除术的患者中,66例(42.3%)因中度/重度腹痛接受了静脉注射哌替啶。术后腹痛患者数量和疼痛评分均随时间下降,内镜切除术后2天仅有少数患者主诉轻度腹痛。多因素分析显示,女性(比值比[OR]为2.88;置信区间[CI]为1.31-6.33)、肿瘤位于胃下三分之一(OR为5.46;CI为2.31-12.92)以及手术时间超过60分钟(OR为2.96;CI为1.26-6.98)是内镜切除术后发生疼痛的显著预测因素。
女性、肿瘤位于胃下三分之一以及手术时间较长与内镜切除术后疼痛显著相关。对于有这些危险因素的患者,建议密切监测并积极处理疼痛。通过这些措施,大多数患者在术后2天内可实现疼痛缓解。